Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection

Latent tuberculosis infection (LTBI) represents a subclinical, asymptomatic mycobacterial state affecting approximately 25% of the global population. The substantial prevalence of LTBI, combined with the risk of progressing to active tuberculosis, underscores its central role in the increasing incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Shleider Carnero Canales, Christian, Marquez Cazorla, Jessica, Furtado Torres, André Henrique, Monteiro Filardi, Eloise T., Di Filippo, Leonardo Delello, Costa, Paulo Inácio, Roque-Borda, Cesar Augusto, Pavan, Fernando Rogério
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610444/
https://www.ncbi.nlm.nih.gov/pubmed/37896169
http://dx.doi.org/10.3390/pharmaceutics15102409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610444/
https://www.ncbi.nlm.nih.gov/pubmed/37896169
http://dx.doi.org/10.3390/pharmaceutics15102409

Ejemplares similares